Crinetics Pharmaceuticals, Inc.
CRNXDelisted Sep 1, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001658247
Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.
Holders of 5% or more of CRNX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Crinetics Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Farallon Capital Management, L.L.C. | 13G/A | 8.50%8.99M shares | – | Aug 3, 20261 filing | Aug 3, 2026 | SEC |
| Farallon Capital Partners, L.P. | 13G/A | 8.50%8.02M shares | +2.50 ppfrom 6.00% | Sep 8, 20252 filings | Feb 5, 2026 | SEC |
| Wellington Management Group LLP | 13G/A | 6.80%7.13M shares | −1.00 ppfrom 7.80% | Feb 6, 20238 filings | Aug 13, 2026 | SEC |
| Driehaus Capital Management LLC | 13G/A | 6.11%6.40M shares | – | Jan 10, 20224 filings | May 15, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 5.19%5.44M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
| Price T Rowe Associates Inc | 13G/A | 5.10%5.36M shares | – | Nov 14, 20242 filings | May 15, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
65 Schedule 13D and 13G filings on Crinetics Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 11, 2022 | OrbiMed Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Struthers Richard Scott | 13G/AOld format | – | – | – | SEC |
| Feb 3, 20224:41 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 10, 2022 | Driehaus Capital Management LLC | 13GOld format | – | New | – | SEC |
| Jan 10, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Oct 29, 2021 | Biotechnology Value Fund L P | 13GOld format | – | New | – | SEC |
| Apr 22, 2021 | Deep Track Capital, LP | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Versant Venture Capital V, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | 5AM Ventures IV, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Vivo Capital VIII, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | OrbiMed Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 5, 2021 | Struthers Richard Scott | 13G/AOld format | – | – | – | SEC |
| Feb 2, 20213:13 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
77 notices from officers, directors and other affiliates planning to sell Crinetics Pharmaceuticals, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Jul 2, 20264:31 PM ET | Jeff KnightOfficer | 47.4K | $1.83M | Jul 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jul 2, 20264:29 PM ET | Rogerio Vivaldi CoelhoDirector | 6.00K | $232.1K | Jul 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 17, 20264:27 PM ET | Stephanie OkeyDirector | 6.90K | $241.5K | Jun 17, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 4, 20264:26 PM ET | Jeff KnightOfficer | 9.48K | $370.1K | May 4, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 14, 20264:37 PM ET | Jeff KnightOfficer | 20.9K | $808.0K | Apr 14, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 13, 20264:36 PM ET | Jeff KnightOfficer | 4.43K | $174.9K | Apr 13, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 8, 20264:49 PM ET | Jeff KnightOfficer | 85.2K | $3.27M | Apr 8, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 18, 20264:30 PM ET | Dana PizzutiOfficer | 24.8K | $938.0K | Mar 18, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 16, 20269:24 AM ET | Jeff KnightOfficer | 25.1K | $941.5K | Mar 16, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 16, 20269:23 AM ET | Stephen BetzOfficer | 26.5K | $994.4K | Mar 16, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 16, 20269:23 AM ET | Richard Scott StruthersDirector · Officer | 45.0K | $1.69M | Mar 16, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 12, 20264:28 PM ET | Rogerio Vivaldi CoelhoDirector | 5.00K | $184.9K | Mar 12, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 3, 20264:32 PM ET | Stephanie S OkeyDirector | 3.00K | $122.0K | Mar 3, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 2, 202610:28 AM ET | Tobin SchilkeOfficer | 6.80K | $280.0K | Mar 2, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 2, 20264:32 PM ET | Dana PizzutiOfficer | 10.0K | $499.4K | Feb 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 5, 20264:43 PM ET | Isabel KalofonosOfficer | 2.50K | $116.8K | Jan 5, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 2, 20264:31 PM ET | Dana PizzutiOfficer | 5.00K | $232.8K | Jan 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 1, 20254:37 PM ET | Dana PizzutiOfficer | 5.00K | $227.8K | Dec 1, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 3, 20254:26 PM ET | Dana PizzutiOfficer | 5.00K | $217.5K | Nov 3, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Oct 1, 20254:30 PM ET | Dana PizzutiOfficer | 5.00K | $208.3K | Oct 1, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 26, 20254:27 PM ET | Matthew K FustDirector | 16.0K | $574.2K | Sep 26, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 26, 20254:09 PM ET | Struthers Richard ScottOfficer · Director | 4.00K | $180.0K | Sep 26, 202510b5-1 | UBS Financial Services Inc. | SEC |
| Sep 2, 20254:41 PM ET | Dana PizzutiOfficer | 5.00K | $154.9K | Sep 2, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 22, 20254:44 PM ET | Dana PizzutiOfficer | 30.0K | $882.0K | Aug 22, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 20, 20254:24 PM ET | Dana PizzutiOfficer | 6.49K | $191.1K | Aug 20, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
Showing the latest 25. See the CRNX notices from the last 12 months